Chemoinformaics analysis of 3,6,9-trimethyl-7-nitro-2,3- dihydronaphtho[1,8-bc]pyran
| Molecular Weight | 257.289 | nRot | 1 |
| Heavy Atom Molecular Weight | 242.169 | nRig | 16 |
| Exact Molecular Weight | 257.105 | nRing | 3 |
| Solubility: LogS | -6.208 | nHRing | 1 |
| Solubility: LogP | 4.873 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 11 |
| nHA | 3 | APOL | 38.5579 |
| nHD | 0 | BPOL | 17.9501 |
| QED | 0.575 |
| Synth | 3.29 |
| Natural Product Likeliness | 0.408 |
| NR-PPAR-gamma | 0.77 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.001 |
| HIA | 0.01 |
| CACO-2 | -4.652 |
| MDCK | 0.0000371 |
| BBB | 0.779 |
| PPB | 0.990976 |
| VDSS | 1.517 |
| FU | 0.00991889 |
| CYP1A2-inh | 0.971 |
| CYP1A2-sub | 0.932 |
| CYP2c19-inh | 0.944 |
| CYP2c19-sub | 0.554 |
| CYP2c9-inh | 0.869 |
| CYP2c9-sub | 0.896 |
| CYP2d6-inh | 0.654 |
| CYP2d6-sub | 0.886 |
| CYP3a4-inh | 0.469 |
| CYP3a4-sub | 0.338 |
| CL | 3.9 |
| T12 | 0.108 |
| hERG | 0.055 |
| Ames | 0.897 |
| ROA | 0.164 |
| SkinSen | 0.947 |
| Carcinogencity | 0.917 |
| EI | 0.942 |
| Respiratory | 0.937 |
| NR-Aromatase | 0.373 |
| Antiviral | Yes |
| Prediction | 0.700202 |